Drug Price Trends for BROMFENAC SODIUM

Average Pharmacy Cost for BROMFENAC SODIUM

These are average pharmacy acquisition costs (net of discounts) from a US national survey

Drug Name	NDC	Price/Unit ($)	Unit	Date
BROMFENAC SODIUM 0.07% EYE DRP	62332-0583-03	19.73263	ML	2024-12-18
BROMFENAC SODIUM 0.07% EYE DRP	75907-0093-03	19.73263	ML	2024-12-18
BROMFENAC SODIUM 0.07% EYE DRP	68180-0433-02	19.73263	ML	2024-12-18
BROMFENAC SODIUM 0.09% EYE DRP	72266-0142-01	22.01423	ML	2024-12-18

Bromfenac Sodium Market Analysis and Price Projections

Introduction to Bromfenac Sodium

Bromfenac sodium is a nonsteroidal anti-inflammatory drug (NSAID) commonly used in ophthalmic solutions for the symptomatic treatment of inflammatory diseases in the external and anterior ocular areas. It is particularly effective in managing post-operative inflammation and pain, especially following cataract surgeries[4].

Global Growth Drivers

The global bromfenac sodium market is driven by several key factors:

• Increasing Prevalence of Ocular Diseases: The rising incidence of ocular diseases such as cataracts and glaucoma is a significant driver. As the global population ages, the demand for effective treatments for these conditions is increasing[1].
• Advancements in Pharmaceutical Formulations: Innovations in formulations, including the use of nanotechnology, have enhanced the bioavailability and efficacy of bromfenac sodium. This has led to better patient outcomes and higher market demand[1].
• Rising Demand for Post-Operative Pain Management: The surge in ophthalmic surgeries, particularly cataract surgeries, has created a high demand for effective post-operative pain management solutions. Bromfenac sodium's anti-inflammatory properties make it a preferred choice in this context[1].

Market Segmentation

The global bromfenac sodium market is segmented based on type and distribution channel:

By Type

• Original Drug: This segment includes branded versions of bromfenac sodium, such as Prolensa and BromSite.
• Generic Drug: Generic versions are becoming increasingly popular due to their cost-effectiveness and similar efficacy to original drugs[2][4].

By Distribution Channel

• Hospital Pharmacies: These are the primary distribution channels, given the frequent use of bromfenac sodium in post-operative care within hospitals.
• Retail Pharmacies: Retail pharmacies also play a significant role, especially for patients who need ongoing treatment.
• Online Pharmacies: The rise of online pharmacies is expanding the reach of bromfenac sodium, making it more accessible to a broader patient base[2][4].

Competitive Landscape

The competitive landscape of the bromfenac sodium market is dynamic, with several key players vying for dominance:

• Market Leaders: Companies such as Qilu Pharma, Senju Pharma, CISEN, Hi-Tech Pharma, Apotex Corp., Iskon Remedies, and Meizilin Pharma are leading the market through innovation, strategic partnerships, and market expansion[2].
• Technological Advancements: The use of advanced manufacturing technologies, including nanotechnology, is a differentiator for market leaders. These technologies enhance the product's efficacy and safety profile[1].

Regional Analysis

The market for bromfenac sodium is spread across various regions, each with its own growth dynamics:

• North America and Europe: These regions are experiencing steady growth driven by advancements in surgical techniques and the adoption of minimally invasive procedures. The introduction of innovative formulations, such as preservative-free bromfenac, is also driving market growth[1].
• Asia-Pacific: Emerging markets in this region, particularly India and China, are witnessing rapid growth due to improving healthcare infrastructure and increasing access to ophthalmic care. The growing middle class in these countries is driving demand for bromfenac sodium[1].
• Middle East and Africa: While currently smaller markets, these regions are expected to expand as healthcare infrastructure improves. Countries like South Africa and the UAE are investing in advanced medical technologies, positioning themselves as potential growth areas[1].

Market Forecast and Projections

The global bromfenac sodium market is poised for significant growth:

• CAGR: The market is expected to grow at a compound annual growth rate (CAGR) of around 6% over the next several years[1].
• Demand Growth: The demand for bromfenac sodium is projected to grow by approximately 5% annually, driven by the increasing incidence of ocular diseases and the growing number of cataract surgeries[1].
• Market Size: By 2031, the global bromfenac sodium market is expected to reach a substantial value, with estimates suggesting a market size in the hundreds of millions of dollars[4].

Price Projections

The pricing of bromfenac sodium can vary based on the formulation and distribution channel:

• Cost: The cost for bromfenac ophthalmic solution can range from around $337 for a 3-milliliter supply to $69.43 for a 1.7-milliliter supply, depending on the concentration and pharmacy[5].
• Discounts and Assistance Programs: Patients can benefit from discount cards, copay cards, and patient assistance programs, although these may vary and are not always available[5].

Key Takeaways

• Growing Demand: The market is driven by the increasing prevalence of ocular diseases and the need for effective post-operative pain management.
• Technological Advancements: Innovations in formulations are enhancing the efficacy and safety of bromfenac sodium.
• Regional Growth: The market is expanding across various regions, with significant growth expected in Asia-Pacific and the Middle East and Africa.
• Competitive Landscape: Market leaders are leveraging advanced technologies and strategic partnerships to maintain their position.
• Price Dynamics: Pricing varies based on formulation and distribution channel, with potential savings through discount programs.

FAQs

1. What is bromfenac sodium used for? Bromfenac sodium is used for the symptomatic treatment of inflammatory diseases in the external and anterior ocular areas, particularly for post-operative inflammation and pain following cataract surgeries[4].

2. What are the key drivers of the global bromfenac sodium market? The key drivers include the increasing prevalence of ocular diseases, advancements in pharmaceutical formulations, and the rising demand for post-operative pain management solutions[1].

3. How is the bromfenac sodium market segmented? The market is segmented by type (original drug and generic drug) and by distribution channel (hospital pharmacies, retail pharmacies, and online pharmacies)[2][4].

4. Which regions are expected to see significant growth in the bromfenac sodium market? North America, Europe, Asia-Pacific, and the Middle East and Africa are expected to see significant growth, with Asia-Pacific and the Middle East and Africa being emerging markets[1].

5. What is the projected CAGR for the global bromfenac sodium market? The market is expected to grow at a CAGR of around 6% over the next several years[1].

Sources

1. Worldwide Bromfenac Sodium Market Research 2024 by Type, Application, Participants, and Countries Forecast to 2030 - PMarketResearch
2. Bromfenac Sodium Market Outlook: Comprehensive Overview and Projections for 2024 - OpenPR
3. Global Bromfenac Sodium (CAS 91714-93-1) Market Insights - Valuates
4. Bromfenac Sodium Market Key Players Analysis 2031 - The Insight Partners
5. Bromfenac ophthalmic Prices, Coupons, Copay Cards & Patient Assistance - Drugs.com